France
Spore.Bio, founded in 2023, is at the forefront of combining AI and light for innovations in microbiology, setting the stage for a new era in microbiological technologies. Their novel approach positions them uniquely in the intersecting sectors of Industrial, Information Technology, and Manufacturing.
Headquartered in France, Spore.Bio recently secured a $23.00M Series A investment on 20 February 2025, demonstrating strong investor confidence. This round attracted attention from esteemed investors, including No Label Ventures, Famille C., Point 72 Ventures, STATION F, Singular, 1st Kind Ventures, Lord David Prior, and LocalGlobe.
The company's slogan, "AI + Light for Microbiology," encapsulates its mission to redefine the microbiological landscape through technology. With strong investor backing and a distinctive technological proposition, they are well-positioned for growth and could be a promising opportunity for investors seeking to capitalize on cutting-edge industrial innovation.
Silgan Unicep
Steripac GmbH